Outsourced R&D Leader Science Exchange Plans Continued Expansion, Raises $28 Million in Series C Funding

Funding led by Norwest Venture Partners with participation from Union Square Ventures, Maverick Capital and Collaborative Fund
Funding led by Norwest Venture Partners with participation from Union Square Ventures, Maverick Capital and Collaborative Fund
CHESTER, PA — (Marketwired) — 04/06/16 –, a worldwide provider of enterprise cloud applications and services for improving sales and channel performanceWill spotlight the company–s sales operations, compensation and performance solutions during theSunday, April 17 – Wednesday, April 20, 2016Planet Hollywood
3667 Las Vegas Blvd. South
Las Vegas, Nev.Optymyze will exhibit in Booth No. 116.Sales operations strategy is a core component in business success for pharmaceutical organizations. As suc
At this year’s PAS-X User Group Meeting in Parsippany, New Jersey/USA, Werum IT Solutions – the market-leading provider of Manufacturing IT Solutions and Manufacturing Execution Systems (MES) for the pharmaceutical industry – and Systec & Solutions, a specialized manufacturer of GMP IT hardware solutions for the pharmaceutical industry, presented a new, jointly developed approach for enhanced usability in controlling pharmaceutical and biopharmaceutical production processes on the shop floor
Werum IT Solutions has released the latest version of its worldwide market-leading Manufacturing Execution System (MES) for the pharmaceutical and biopharmaceutical industries. The new PAS-X V3.1.7 software offers new levels of usability, and serves to further improve overall operational efficiencies.
The multinational pharmaceutical and consumer goods manufacturer Johnson & Johnson updated their site in Geel, Belgium, to PAS-X V3.1.5. The Geel site plays a key role for Johnson & Johnson: In this plant, the company manufactures important active pharmaceutical ingredients, for instance for cancer medication, that are then processed further in other facilities around the globe.
Actavis, the fast-growing generics manufacturer, upgrades to the latest PAS-X Version V3.1.6 at their Bulgarian site in Dupnitsa. With an annual output of more than 6bn tablets, Dupnitsa is one of the largest manufacturing facility of Actavis worldwide.
Octapharma, one of the largest independent manufacturers of human protein products worldwide, has added the PAS-X Track & Trace Serialization Aggregation solution to Werum–s PAS-X at their production site in Vienna.
The Japanese biotech company UNIGEN Inc. has taken Werum-s PAS-X Manufacturing Execution System (MES) into operation within a record time of only four months. The short implementation time was possible because the company relied on a standard solution. PAS-X is operational with all functionalities out of the box. UNIGEN implemented PAS-X using Werum’s four-phased fast-track implementation methodology: Ready, Fit, Build and Run. Part of the project and a big success element was the flexible and e
In cooperation with the PAS-X User Community, Werum further improved the leading Manufacturing Execution System (MES) for pharmaceutical and biotechnological production. "We integrated new features and improved the usability, making working with PAS-X even easier and more efficient", says Robert Welter, Head of PAS-X Product Management, Werum IT Solutions GmbH. "PAS-X is a functionally complete and scalable MES out of the box, which widely automates actions that previously had to
Cloud-Based Platform Provides Real-Time Data Insights for Clinical Trials